prednisone has been researched along with Polymyalgia Rheumatica in 260 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Polymyalgia Rheumatica: A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with GIANT CELL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of prednisone plus infliximab with that of prednisone plus placebo in patients with newly diagnosed polymyalgia rheumatica." | 9.12 | Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. ( Boiardi, L; Cantini, F; Catanoso, MG; Cimmino, M; Gerli, R; Hunder, GG; Klersy, C; Macchioni, P; Manganelli, P; Manzini, C; Paolazzi, G; Salvarani, C; Trotta, A, 2007) |
| "To compare the efficacy and safety of prednisone plus methotrexate and prednisone alone in patients with polymyalgia rheumatica." | 9.11 | Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. ( Caporali, R; Cimmino, MA; Ferraccioli, G; Gerli, R; Klersy, C; Montecucco, C; Salvarani, C, 2004) |
| "To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)." | 9.08 | Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? ( Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ, 1996) |
| "The objectives were to determine the efficacy and safety of nasal salmon calcitonin 200 IU daily in the prevention of corticosteroid-induced osteoporosis." | 9.08 | Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. ( Adachi, JD; Bell, MJ; Bensen, WG; Bianchi, FA; Cividino, AA; Craig, GL; Gent, M; Gordon, M; Roberts, R; Sebaldt, RJ; Steele, M; Sturtridge, WC; Themeles, E; Tugwell, P, 1997) |
| "To determine whether tenidap treatment would allow reduction or replacement of systemic corticosteroid treatment in patients with polymyalgia rheumatica (PMR)." | 9.08 | Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study. ( Bjarnason, D; Bryant, G; Cohen, M; Engelbrecht, J; Hunder, GG; Littman, BH; Mertz, L; Weaver, A, 1995) |
| "This study is concerned with an evaluation of the effects of glucocorticoids (GC) on adiponectin and leptin concentrations in patients with polymyalgia rheumatica (PMR)." | 7.76 | Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica. ( Andraghetti, G; Briatore, L; Cimmino, MA; Cordera, R; Cutolo, M; Parodi, M; Salani, B, 2010) |
| " Possible predisposing factors included treatment with prednisone pulse therapy for obstructive pulmonary disease and prior polymyalgia rheumatica." | 7.73 | [Spontaneous bilateral rupture of the Achilles tendon in an elderly woman undergoing prednisone pulse therapy with a history of polymyalgia rheumatica]. ( de Wolf, MM; Frijns, CJ; van der Krans, A, 2006) |
| "To examine the efficacy and steroid sparing potential of methotrexate (MTX) in the treatment of polymyalgia rheumatica (PMR) without giant cell arteritis." | 7.69 | The use of methotrexate in polymyalgia rheumatica. ( Dietzen, CJ; Feinberg, GD; Feinberg, HL; Schrepferman, CG; Sherman, JD, 1996) |
| "The aim of this study was to evaluate CD8 lymphocyte subsets in active polymyalgia rheumatica (PMR), to determine whether low percentages of CD8+ cells could be used to differentiate PMR from elderly-onset (EORA) and adult rheumatoid arthritis (RA), and to investigate the effects of prednisone on CD8 lymphocyte subsets." | 7.69 | CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy. ( Beltrandi, E; Boiardi, L; Casadei Maldini, M; Macchioni, P; Mancini, R; Portioli, I; Salvarani, C, 1996) |
| "The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 7.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
| "Three patients (one with polymyalgia rheumatica with jaw claudication and two with biopsy-proven giant cell arteritis) were initially treated using prednisone (40-60 mg daily)." | 7.67 | Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. ( Krall, PL; Mazanec, DJ; Wilke, WS, 1989) |
| "The transcapillary escape rate of albumin was measured in 27 consecutive patients with inflammatory rheumatic diseases before and after 1 and 7 days of prednisone treatment in doses of 45 mg/day." | 7.66 | Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases. ( Hansen, TM; Junker, P; Lorenzen, I; Manthorpe, R; Utne, HE, 1979) |
| "Steroids are the only treatment of polymyalgia rheumatica (PMR)." | 6.68 | Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. ( Bartoli, E; Casatta, L; De Vita, S; Ferraccioli, G; Salaffi, F, 1996) |
| "Deflazacort is an oxazoline derivative of prednisolone with documented calcium-sparing properties when compared to prednisone on a weight basis." | 6.66 | Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica. ( Egsmose, C; Jørgensen, S; Krogsgaard, MR; Lund, B, 1987) |
| "Among patients with active polymyalgia rheumatica despite prednisone therapy, tocilizumab, compared with placebo, resulted in a significantly greater percentage of patients with a CRP PMR-AS less than 10 with reduced prednisone requirements at week 24." | 5.51 | Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial. ( Carvajal-Alegria, G; Chary-Valckenaere, I; Chiche, L; Cornec, D; Dernis, E; Dervieux, B; Devauchelle-Pensec, V; Direz, G; Fautrel, BJ; Felten, R; Gottenberg, JE; Guellec, D; Hilliquin, P; Le Henaff, C; Marhadour, T; Nowak, E; Perdriger, A; Richez, C; Saraux, A; Toussirot, E; Truchetet, ME; Wendling, D, 2022) |
| "the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking." | 5.37 | The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. ( Caporali, R; Cimmino, MA; Montecucco, C; Parodi, M, 2011) |
| "We used the Club Rhumatisme et Inflammation (CRI; 89 patients with PMR) and the Tolerance and Efficacy of tocilizumab iN pOlymyalgia Rheumatica (TENOR; 20 patients with recent-onset PMR naive to glucocorticoid who received three tocilizumab infusions, at weeks 0, 4 and 8, followed by prednisone from weeks 12 to 24) cohorts." | 5.27 | Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable. ( Berthelot, JM; Cornec, D; De Bandt, M; Devauchelle-Pensec, V; Gouillou, M; Guellec, D; Jousse-Joulin, S; Marhadour, T; Saraux, A; Saraux, L, 2018) |
| "To compare the efficacy of prednisone plus infliximab with that of prednisone plus placebo in patients with newly diagnosed polymyalgia rheumatica." | 5.12 | Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. ( Boiardi, L; Cantini, F; Catanoso, MG; Cimmino, M; Gerli, R; Hunder, GG; Klersy, C; Macchioni, P; Manganelli, P; Manzini, C; Paolazzi, G; Salvarani, C; Trotta, A, 2007) |
| "To compare the efficacy and safety of prednisone plus methotrexate and prednisone alone in patients with polymyalgia rheumatica." | 5.11 | Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. ( Caporali, R; Cimmino, MA; Ferraccioli, G; Gerli, R; Klersy, C; Montecucco, C; Salvarani, C, 2004) |
| "To determine whether tenidap treatment would allow reduction or replacement of systemic corticosteroid treatment in patients with polymyalgia rheumatica (PMR)." | 5.08 | Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study. ( Bjarnason, D; Bryant, G; Cohen, M; Engelbrecht, J; Hunder, GG; Littman, BH; Mertz, L; Weaver, A, 1995) |
| "The objectives were to determine the efficacy and safety of nasal salmon calcitonin 200 IU daily in the prevention of corticosteroid-induced osteoporosis." | 5.08 | Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. ( Adachi, JD; Bell, MJ; Bensen, WG; Bianchi, FA; Cividino, AA; Craig, GL; Gent, M; Gordon, M; Roberts, R; Sebaldt, RJ; Steele, M; Sturtridge, WC; Themeles, E; Tugwell, P, 1997) |
| "To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)." | 5.08 | Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? ( Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ, 1996) |
| "Deflazacort and prednisone were given to 26 patients with rheumatoid arthritis, polymyalgia rheumatica, or other chronic inflammatory diseases, in a double-blind study." | 5.07 | A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. ( Coulton, L; de Broe, M; Doherty, SM; Galloway, J; Gray, RE; Kanis, JA, 1991) |
| " The other study examined a methylprednisolone versus a prednisone taper for polymyalgia rheumatica and reported 100% and 89% remission rates, respectively, at 26 weeks." | 5.05 | Corticosteroid Tapering Regimens in Rheumatic Disease: A Systematic Review. ( Campbell, AM; Erstad, BL; Martin, JR, 2020) |
| "The case of a 75-year-old woman diagnosed with polymyalgia rheumatica (PMR), treated with low doses of prednisone, and with clinical and analytical remission is reported." | 4.12 | Giant cell arteritis with spontaneous remission. ( Alonso-Valdivielso, JL; Álvarez-Lario, B; Colazo-Burlato, M; Lorenzo-Martín, JA; Macarrón-Vicente, JL, 2022) |
| "An 82-year-old woman with polymyalgia rheumatica (PMR) on prednisone 7 mg daily was admitted to an acute stroke unit with a right homonymous hemianopia, a left posterior cerebral artery occlusion and occipital lobe infarct." | 3.85 | Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale. ( Gutteridge, DH; Mastaglia, FL, 2017) |
| "This study is concerned with an evaluation of the effects of glucocorticoids (GC) on adiponectin and leptin concentrations in patients with polymyalgia rheumatica (PMR)." | 3.76 | Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica. ( Andraghetti, G; Briatore, L; Cimmino, MA; Cordera, R; Cutolo, M; Parodi, M; Salani, B, 2010) |
| "A man (age: 76 years) on prednisone and leflunomide for polymyalgia rheumatica developed spontaneous severe haematomas." | 3.76 | [Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica]. ( Braunert, L; Bruegel, M; Niederwieser, D; Pfrepper, C; Thiery, J, 2010) |
| "The authors studied a 72-year-old man with polymyalgia rheumatica who, after taking 100 mg of prednisone for 3 months, developed a psychosis followed by dementia." | 3.73 | Steroid dementia: an overlooked diagnosis? ( Sacks, O; Shulman, M, 2005) |
| " Although her symptoms deteriorated as pregnancy progressed, she drastically improved by treatment with prednisone." | 3.73 | Acute onset of polymyalgia rheumatica in pregnancy. ( Maruo, T; Ohara, N; Sasaki, H; Washio, M, 2005) |
| " Possible predisposing factors included treatment with prednisone pulse therapy for obstructive pulmonary disease and prior polymyalgia rheumatica." | 3.73 | [Spontaneous bilateral rupture of the Achilles tendon in an elderly woman undergoing prednisone pulse therapy with a history of polymyalgia rheumatica]. ( de Wolf, MM; Frijns, CJ; van der Krans, A, 2006) |
| "Among 127 consenting patients, 81 with rheumatoid arthritis taking nonsteroidal antiinflammatory drugs (13 diclofenac, 20 naproxen) or disease modifying antirheumatic drugs (25 sulfasalazine, 23 methotrexate), 17 patients with polymyalgia rheumatica taking prednisone, and 29 patients with gout taking daily prophylactic colchicine (n = 12) or the uric acid lowering drugs allopurinol (10) or benzbromaron (7), 104 used their medication from a regular medication bottle fitted with a special cap containing microelectronics capable of recording time and date of opening and closing, defined as a medication event." | 3.72 | The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. ( de Klerk, E; Landewé, R; van der Linden, S; van der Tempel, H; van der Heijde, D, 2003) |
| " One patient with polymyalgia rheumatica who developed the inhibitor while receiving prednisone responded to single agent rituximab." | 3.71 | Rituximab in the treatment of acquired factor VIII inhibitors. ( Asch, AS; Cho, HJ; Michelis, MA; Peerschke, EI; Schechter, GP; Weksler, BB; Wiestner, A; Zeller, JA, 2002) |
| " In the year before the current admission she developed myalgias and was treated for polymyalgia rheumatica with low-dose prednisone." | 3.70 | [Clinical thinking and decision making in the practice. A patient with fever of unknown origin]. ( de Meijer, PH; Meinders, AE; Schippers, EF, 1998) |
| "To examine the efficacy and steroid sparing potential of methotrexate (MTX) in the treatment of polymyalgia rheumatica (PMR) without giant cell arteritis." | 3.69 | The use of methotrexate in polymyalgia rheumatica. ( Dietzen, CJ; Feinberg, GD; Feinberg, HL; Schrepferman, CG; Sherman, JD, 1996) |
| "The aim of this study was to evaluate CD8 lymphocyte subsets in active polymyalgia rheumatica (PMR), to determine whether low percentages of CD8+ cells could be used to differentiate PMR from elderly-onset (EORA) and adult rheumatoid arthritis (RA), and to investigate the effects of prednisone on CD8 lymphocyte subsets." | 3.69 | CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy. ( Beltrandi, E; Boiardi, L; Casadei Maldini, M; Macchioni, P; Mancini, R; Portioli, I; Salvarani, C, 1996) |
| "The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 3.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
| "Three patients (one with polymyalgia rheumatica with jaw claudication and two with biopsy-proven giant cell arteritis) were initially treated using prednisone (40-60 mg daily)." | 3.67 | Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. ( Krall, PL; Mazanec, DJ; Wilke, WS, 1989) |
| "We have described a 60-year-old woman with polymyalgia rheumatica treated initially with prednisone but ultimately with azathioprine and cyclophosphamide." | 3.67 | Trigeminal herpes zoster causing mandibular osteonecrosis and spontaneous tooth exfoliation. ( Canter, HG; Manz, HJ; Melton, J, 1986) |
| "The transcapillary escape rate of albumin was measured in 27 consecutive patients with inflammatory rheumatic diseases before and after 1 and 7 days of prednisone treatment in doses of 45 mg/day." | 3.66 | Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases. ( Hansen, TM; Junker, P; Lorenzen, I; Manthorpe, R; Utne, HE, 1979) |
| "A 70-year-old woman presenting with typical polymyalgia rheumatica (PMR) and a normal temporal artery biopsy appeared to respond completely to low-dose prednisone therapy." | 3.65 | Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica. ( Bartholomew, LE; Mika, P; Rynes, RI, 1977) |
| "Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events." | 2.82 | Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study. ( Berthelot, JM; Cornec, D; De Bandt, M; Devauchelle-Pensec, V; Garrigues, F; Gouillou, M; Jousse-Joulin, S; Marhadour, T; Querellou, S; Renaudineau, Y; Saraux, A, 2016) |
| "The study group comprised patients with relapsing PMR who were not able to reduce their prednisone dosage below 7." | 2.73 | Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study. ( Boiardi, L; Catanoso, MG; Macchioni, P; Pipitone, N; Salvarani, C, 2007) |
| "Sixty-one patients with PMR were randomly assigned to two groups, the 32 patients in the treatment group treated with YHD two doses per day combined with prednisone and the 29 patients in the control group treated with prednisone alone." | 2.73 | [Clinical observation on effect of modified Yanghe Decoction combined with glycocorticoid for treatment of polymyalgia rheumatica]. ( Fu, HZ, 2007) |
| "Relapses are common in patients with PMR." | 2.72 | Predicting the risk of relapse in polymyalgia rheumatica: novel insights. ( Atienza-Mateo, B; Blanco, R; Castañeda, S; González-Gay, MA; Prieto-Peña, D, 2021) |
| "Steroids are the only treatment of polymyalgia rheumatica (PMR)." | 2.68 | Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. ( Bartoli, E; Casatta, L; De Vita, S; Ferraccioli, G; Salaffi, F, 1996) |
| "Deflazacort is an oxazoline derivative of prednisolone with documented calcium-sparing properties when compared to prednisone on a weight basis." | 2.66 | Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica. ( Egsmose, C; Jørgensen, S; Krogsgaard, MR; Lund, B, 1987) |
| " Adjunctive methotrexate may reduce cumulative glucocorticoid dosage by 20% to 44% and relapses by 36% to 54% in both PMR and GCA." | 2.53 | Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. ( Buttgereit, F; Dasgupta, B; Dejaco, C; Matteson, EL, 2016) |
| " Steroids are the standard treatment for PMR but their dosage requires adjustment depending on clinical picture, co-morbid conditions and adverse effects." | 2.44 | Polymyalgia rheumatica: clinical picture and principles of treatment. ( Zimmermann-Górska, I, 2008) |
| "If untreated, polymyalgia rheumatica may result in significant disability." | 2.43 | Polymyalgia rheumatica and giant cell arteritis. ( Gilliland, W; Unwin, B; Williams, CM, 2006) |
| "The association of bronchiolitis obliterans organizing pneumonia (BOOP) with polymyalgia rheumatica is rare, and only one case has previously been described." | 2.40 | Bronchiolitis obliterans organizing pneumonia associated with polymyalgia rheumatica. ( Marti, D; Medici, TC; Stey, C; Truninger, K; Vogt, P, 1999) |
| "Out of 47 patients with amaurosis, 23 remained with permanent unit or bilateral blindness." | 2.39 | [Giant cell arteritis. A study of 191 patients]. ( Armona, J; Blanco, R; Fernández-Sueiro, JL; Figueroa, M; González-Gay, MA; Martínez-Taboada, V; Rodríguez-Valverde, V, 1995) |
| "We report a case of biopsy-proven temporal arteritis and polymyalgia rheumatica with improved clinical symptoms with steroid treatment but with subsequent renal failure while on steroids." | 2.38 | Renal failure in temporal arteritis. ( Barril, G; Bernis, C; Canton, CG; García, A; Osorio, C; Paraiso, V; Rincón, B; Traver, JA, 1992) |
| "9) and higher baseline prednisone dosage (RR = 1." | 1.91 | Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica. ( Bartoloni, E; Bogdanos, D; Bursi, R; Cafaro, G; Fiumicelli, E; Gerli, R; Perricone, C; Riccucci, I, 2023) |
| "Glucocorticoids are associated with serious side effects related to dosing and time of use." | 1.91 | Development of a web tool to calculate the cumulative dose of glucocorticoids. ( Díaz-González, F; Guerra-Rodríguez, M; Loricera, J; Montero-Pastor, N; Moriano, C; Sánchez-Alonso, F; Sánchez-Costa, JT, 2023) |
| "Reactive arthritis was diagnosed in 1 patient who presented with swelling in both hands and wrists 2 days after being diagnosed with COVID-19." | 1.72 | Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. ( Aung, T; Ballester, A; Cheav, S; Chen, C; Metyas, S, 2022) |
| "Dermatomyositis is a rare, idiopathic inflammatory myopathy characterized by erythematous skin lesions and inflammation of skeletal muscles." | 1.56 | Autoimmune Conditions: Polymyalgia Rheumatica and Dermatomyositis. ( Ghetu, MV, 2020) |
| "Relapse was defined as either new disease activity after a period of remission or worsening disease activity." | 1.42 | Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. ( Carette, S; Cuthbertson, D; Hoffman, GS; Kermani, TA; Khalidi, NA; Koening, CL; Langford, CA; Maksimowicz-McKinnon, K; McAlear, CA; Merkel, PA; Monach, PA; Seo, P; Warrington, KJ; Ytterberg, SR, 2015) |
| "The treatment with prednisone resulted in a rapid resolution of clinical symptoms." | 1.42 | Polymyalgia rheumatica in a patient with splenic marginal zone lymphoma - a case report. ( Gawroński, K; Kisiel, B; Rzepecki, P; Tłustochowicz, W, 2015) |
| "Osteoporosis was more common in patients with relapses compared to those without (65% vs 32%, p = 0." | 1.40 | Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. ( Alba, MA; Butjosa, M; Cid, MC; Corbera-Bellalta, M; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Planas-Rigol, E; Prieto-González, S; Tavera-Bahillo, I, 2014) |
| "Polymyalgia rheumatica is characterized by aching and stiffness of the shoulder, the pelvic girdles and the neck." | 1.40 | [Peripheral arthritis in polymyalgia rheumatica]. ( Manovitch, Z; Mouallem, M, 2014) |
| " Adequate glucocorticoid dosing and gradual tapering are key to treatment success." | 1.39 | Polymyalgia rheumatica and giant cell arteritis: how best to approach these related diseases. ( Freeman, AC; Rapoport, RJ, 2013) |
| "Giant cell arteritis is rarely recognized in Latin America." | 1.38 | Giant cell arteritis in Mexican patients. ( Alba, MA; Flores-Suárez, LF; Mena-Madrazo, JA; Reyes, E, 2012) |
| " At each visit, they assessed disease activity using a visual analog scale for physician's global assessment (VASph) and recorded whether a flare was diagnosed and/or the GC dosage was changed." | 1.38 | Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. ( Berthelot, JM; Binard, A; Cleuziou, C; De Bandt, M; Saraux, A, 2012) |
| "Clinical relapse was not statistically linked to the initial dose of corticoids." | 1.37 | Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica. ( Garrot, JF; Gérard, N; Gros, F; Guillibert-Karras, C; Julien, L; Maillefert, JF; Ornetti, P; Pascaud, F; Peere, T; Petit-Perrin, M; Piroth, C; Tavernier, C, 2011) |
| "Upon treatment with prednisone, the pain quickly decreased and 3 months later the inflammatory changes visible on MRI were clearly reduced." | 1.37 | [Low back pain and MRI-abnormalities: atypical polymyalgia rheumatica]. ( Bravenboer, B; de Rijk, MC; Pijpers, R; Wlazlo, N, 2011) |
| "the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking." | 1.37 | The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. ( Caporali, R; Cimmino, MA; Montecucco, C; Parodi, M, 2011) |
| " This dosage is diminished very gradually according to a uniform treatment schedule during a period of 3 months, thereafter depending on the clinical course." | 1.36 | [Dutch College of General Practitioner's practice guideline on polymyalgia rheumatica and temporal arteritis]. ( Dubbeld, P; Eizenga, WH; Geijer, RM; Goudswaard, AN; Hakvoort, L, 2010) |
| "She simultaneously developed pulmonary nocardiosis as well as a soft tissue infection and osteomyelitis by mycobacterium abscessus." | 1.35 | [Pulmonary nodules in a patient on long-term steroid treatment]. ( Bürgi, U; Hurni, Ch; Perrig, M; Rauch, A; Schoenenberger, AW; Trost, N, 2008) |
| "Polymyalgia rheumatica is infrequently the initial manifestation of underlying malignancy." | 1.33 | Polymyalgia rheumatica and breast cancer. ( Gilliland, WR; Keith, MP, 2006) |
| "Prednisone was prescribed in 148 patients (mean dose 23 +/- 14 mg) for a mean time of 28 +/- 29 mo." | 1.30 | Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. ( Bahlas, S; Davis, P; Ramos-Remus, C, 1998) |
| "Mild cholestasis was present in four of the seven patients for whom data were available." | 1.30 | [RS3PE: a clinical diagnosis, a prognosis more simple than its name]. ( Azais, I; Becq-Giraudon, B; Paccalin, M; Ramassamy, A; Roblot, P; Zaim, A, 1998) |
| "Polymyalgia rheumatica is a heterogeneous disease with variations in the treatment duration and dose of corticosteroids required for suppression of symptoms." | 1.30 | Corticosteroid requirements in polymyalgia rheumatica. ( Evans, JM; Fulbright, JW; Goronzy, JJ; Hunder, GG; Weyand, CM, 1999) |
| "Relapses were frequent in both isolated PMR and PMR associated with GCA." | 1.30 | The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. ( Dababneh, A; García-Porrúa, C; González-Gay, MA; Hajeer, A; Ollier, WE; Vázquez-Caruncho, M, 1999) |
| "Giant cell arteritis is usually easy to recognize, easy to treat, and satisfying to manage." | 1.29 | Giant cell arteritis: diagnosis and management. ( Bais, R; Kachroo, A; Panush, RS; Tello, C, 1996) |
| " The close correlation of plasma IL-6 concentrations with clinical symptoms suggests a direct contribution of this cytokine to the disease manifestations and presents the possibility that monitoring IL-6 levels would be useful in making decisions on adjustment of corticosteroid dosage in individual patients." | 1.29 | Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. ( Fulbright, JW; Goronzy, JJ; Hunder, GG; Roche, NE; Wagner, AD; Weyand, CM, 1993) |
| "This is the first description of temporal arteritis, polymyalgia and aortic dissection in siblings." | 1.29 | [Giant cell arteritis and aortic dissection in 2 siblings]. ( Salomon, F; Thurnheer, R, 1993) |
| "Myelodysplastic syndromes are a group of clonal hematopoietic stem cell disorders leading to peripheral cytopenias and a high probability of leukemic transformation." | 1.29 | An association of polymyalgia rheumatica with myelodysplastic syndromes. ( Bennett, RM; Kohli, M, 1994) |
| "We describe 10 female patients with temporal arteritis (TA) and/or polymyalgia rheumatica (PMR) who presented with upper-extremity ischemia." | 1.28 | Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. ( Bachet, P; Du Colombier, PB; Dumontet, CM; Ninet, JP; Pasquier, JH; Stewart, MD, 1990) |
| "Prednisone has to be continued over a large period of time creating adverse effects in elderly people unless minimal doses are used." | 1.28 | [Polymyalgia rheumatica and temporal arteritis. Observations on prognosis and treatment]. ( Auquier, L; Paolaggi, JB, 1990) |
| "Thirty-five cases of cranial arteritis in an Australian population have been analysed." | 1.27 | Cranial arteritis. A twenty-year review of cases. ( Koorey, DJ, 1984) |
| "In addition to cranial arteritis, the three other variants of giant cell arteritis may also lead to neurological symptoms: polymyalgia rheumatica, occult giant cell arteritis, and inflammatory aortic arch syndrome of elderly persons." | 1.27 | Giant cell arteritis and its variants. ( Gerber, NJ, 1984) |
| " Seventy-five patients received corticosteroids, with a mean prednisone dosage of 22." | 1.27 | Polymyalgia rheumatica. Duration of therapy and long-term outcome. ( Ayoub, WT; Franklin, CM; Torretti, D, 1985) |
| "Polymyalgia rheumatica is a relatively common syndrome of older patients, mostly white, manifested by aching and morning stiffness of the pelvic and shoulder girdles and accompanied by a rapid erythrocyte sedimentation rate." | 1.27 | Polymyalgia rheumatica and giant cell arteritis. ( Healey, LA; Wilske, KR, 1984) |
| "The authors report two cases of Horton's disease and one case of rhizomelic pseudopolyarthritis treated initially with delta-cortisone with a very rapid favourable result." | 1.27 | [Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis]. ( Doury, P; Eulry, F; Masson, C; Maurel, C; Pattin, S; Tabaraud, F, 1983) |
| "Carpal tunnel syndrome was seen in four patients (10%)." | 1.26 | Skeletal manifestations of polymyalgia rheumatica. ( Miller, LD; Stevens, MB, 1978) |
| "After steroid treatment, the polymyalgia rheumatica and dementia rapidly resolved and the CT scan and EEG became normal." | 1.26 | Polymyalgia rheumatica with diffuse cerebral disease responding rapidly to steroid therapy. ( Bates, D; Nightingale, S; Venables, GS, 1982) |
| "Polymyalgia rheumatica is probably a stage of the same disease." | 1.26 | Giant cell arteritis and blindness. ( Sochocky, S, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 98 (37.69) | 18.7374 |
| 1990's | 53 (20.38) | 18.2507 |
| 2000's | 41 (15.77) | 29.6817 |
| 2010's | 54 (20.77) | 24.3611 |
| 2020's | 14 (5.38) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez-Lario, B | 1 |
| Lorenzo-Martín, JA | 1 |
| Colazo-Burlato, M | 1 |
| Macarrón-Vicente, JL | 1 |
| Alonso-Valdivielso, JL | 1 |
| Rosenberg, H | 1 |
| Halman, S | 1 |
| Yadav, K | 1 |
| Metyas, S | 1 |
| Chen, C | 1 |
| Aung, T | 1 |
| Ballester, A | 1 |
| Cheav, S | 1 |
| Devauchelle-Pensec, V | 4 |
| Carvajal-Alegria, G | 1 |
| Dernis, E | 1 |
| Richez, C | 1 |
| Truchetet, ME | 1 |
| Wendling, D | 6 |
| Toussirot, E | 1 |
| Perdriger, A | 1 |
| Gottenberg, JE | 1 |
| Felten, R | 1 |
| Fautrel, BJ | 1 |
| Chiche, L | 1 |
| Hilliquin, P | 1 |
| Le Henaff, C | 1 |
| Dervieux, B | 1 |
| Direz, G | 1 |
| Chary-Valckenaere, I | 1 |
| Cornec, D | 3 |
| Guellec, D | 2 |
| Marhadour, T | 3 |
| Nowak, E | 1 |
| Saraux, A | 4 |
| Perricone, C | 1 |
| Cafaro, G | 1 |
| Fiumicelli, E | 1 |
| Bursi, R | 1 |
| Bogdanos, D | 1 |
| Riccucci, I | 1 |
| Gerli, R | 3 |
| Bartoloni, E | 1 |
| Montero-Pastor, N | 1 |
| Sánchez-Costa, JT | 1 |
| Guerra-Rodríguez, M | 1 |
| Sánchez-Alonso, F | 1 |
| Moriano, C | 1 |
| Loricera, J | 1 |
| Díaz-González, F | 1 |
| Spiera, RF | 1 |
| Unizony, S | 2 |
| Warrington, KJ | 3 |
| Sloane, J | 1 |
| Giannelou, A | 1 |
| Nivens, MC | 1 |
| Akinlade, B | 1 |
| Wong, W | 1 |
| Bhore, R | 1 |
| Lin, Y | 1 |
| Buttgereit, F | 3 |
| Rubbert-Roth, A | 1 |
| Yancopoulos, GD | 1 |
| Marrache, F | 1 |
| Patel, N | 1 |
| Dasgupta, B | 3 |
| Warren, CJ | 1 |
| Jardine, DL | 1 |
| Cawood, TJ | 1 |
| Milchert, M | 1 |
| Brzosko, M | 1 |
| Campbell, AM | 1 |
| Martin, JR | 1 |
| Erstad, BL | 1 |
| Ghetu, MV | 1 |
| Giraud, N | 1 |
| Prati, C | 4 |
| Verhoeven, F | 4 |
| Prieto-Peña, D | 1 |
| Castañeda, S | 1 |
| Atienza-Mateo, B | 1 |
| Blanco, R | 4 |
| González-Gay, MA | 5 |
| Spiera, R | 3 |
| Unizony, SH | 2 |
| Bao, M | 1 |
| Luder, Y | 1 |
| Han, J | 1 |
| Pavlov, A | 1 |
| Stone, JH | 3 |
| Brambilla, L | 1 |
| Esposito, L | 1 |
| Nazzaro, G | 1 |
| Tourlaki, A | 1 |
| Herbaut, A | 1 |
| Qu-Knafo, L | 1 |
| Abad, S | 1 |
| Dhote, R | 1 |
| Giocanti-Aurégan, A | 1 |
| Gutteridge, DH | 1 |
| Mastaglia, FL | 1 |
| Jones, O | 1 |
| Birrell, F | 1 |
| Saraux, L | 1 |
| Berthelot, JM | 3 |
| De Bandt, M | 3 |
| Jousse-Joulin, S | 2 |
| Gouillou, M | 2 |
| Charpentier, A | 1 |
| Sondag, M | 1 |
| Guillot, X | 3 |
| Teixeira, M | 1 |
| Greenlund, LS | 1 |
| Siddiqi, N | 1 |
| Gulati, G | 1 |
| Ware, AE | 1 |
| Terré, A | 1 |
| Lidove, O | 1 |
| Georges, O | 1 |
| Mesnildrey, P | 1 |
| Chennebault, H | 1 |
| Ziza, JM | 1 |
| Pioro, MH | 1 |
| Giollo, A | 1 |
| Rossini, M | 2 |
| Bettili, F | 1 |
| Ghellere, F | 1 |
| Fracassi, E | 2 |
| Idolazzi, L | 2 |
| Gatti, D | 2 |
| Viapiana, O | 2 |
| Buckley, L | 1 |
| Humphrey, MB | 1 |
| Liozon, E | 1 |
| Delmas, C | 1 |
| Dumonteil, S | 1 |
| Dumont, A | 1 |
| Gondran, G | 1 |
| Bezanahary, H | 1 |
| Aouba, A | 1 |
| Fauchais, AL | 1 |
| Ly, KH | 1 |
| de Boysson, H | 1 |
| Weil-Verhoeven, D | 1 |
| Di Martino, V | 1 |
| Freeman, AC | 1 |
| Rapoport, RJ | 1 |
| Hafner, F | 1 |
| Haas, E | 1 |
| Belaj, K | 1 |
| Froehlich, H | 1 |
| Gary, T | 1 |
| Eller, P | 1 |
| Brodmann, M | 1 |
| Stabile, A | 1 |
| Boulahdour, H | 2 |
| Camellino, D | 1 |
| Morbelli, S | 1 |
| Paparo, F | 1 |
| Massollo, M | 1 |
| Sambuceti, G | 1 |
| Cimmino, MA | 5 |
| Faez, S | 1 |
| Lobo, AM | 1 |
| Papaliodis, GN | 1 |
| Sobrin, L | 1 |
| Mori, S | 1 |
| Koga, Y | 1 |
| Manovitch, Z | 1 |
| Mouallem, M | 1 |
| Troplini, S | 1 |
| Adami, S | 1 |
| Alba, MA | 2 |
| García-Martínez, A | 2 |
| Prieto-González, S | 1 |
| Tavera-Bahillo, I | 1 |
| Corbera-Bellalta, M | 1 |
| Planas-Rigol, E | 1 |
| Espígol-Frigolé, G | 4 |
| Butjosa, M | 1 |
| Hernández-Rodríguez, J | 3 |
| Cid, MC | 5 |
| Benucci, M | 1 |
| Olivito, B | 1 |
| Manfredi, M | 1 |
| Meacci, F | 1 |
| Infantino, M | 1 |
| Li Gobbi, F | 1 |
| Sarzi-Puttini, P | 1 |
| Marcassa, C | 1 |
| Atzeni, F | 1 |
| Kisiel, B | 1 |
| Gawroński, K | 1 |
| Rzepecki, P | 1 |
| Tłustochowicz, W | 1 |
| Kermani, TA | 2 |
| Cuthbertson, D | 1 |
| Carette, S | 1 |
| Hoffman, GS | 1 |
| Khalidi, NA | 1 |
| Koening, CL | 1 |
| Langford, CA | 1 |
| Maksimowicz-McKinnon, K | 1 |
| McAlear, CA | 1 |
| Monach, PA | 1 |
| Seo, P | 1 |
| Merkel, PA | 1 |
| Ytterberg, SR | 1 |
| Lindeboom, R | 1 |
| de Rooij, SE | 1 |
| van Munster, BC | 1 |
| Davee, RA | 1 |
| Ganti, N | 1 |
| Gonzalez, EB | 1 |
| Renaudineau, Y | 1 |
| Querellou, S | 1 |
| Garrigues, F | 1 |
| Füeßl, HS | 1 |
| Stiefelhagen, P | 1 |
| Wirsum, C | 1 |
| Glaser, C | 1 |
| Gutenberger, S | 1 |
| Keller, B | 1 |
| Unger, S | 1 |
| Voll, RE | 1 |
| Vach, W | 1 |
| Ness, T | 1 |
| Warnatz, K | 1 |
| Lally, L | 1 |
| Forbess, L | 1 |
| Hatzis, C | 1 |
| Dejaco, C | 3 |
| Matteson, EL | 3 |
| Eguia, HA | 1 |
| Parodi Garcia, JF | 1 |
| Ramas Diez, C | 1 |
| Eguia A, EA | 1 |
| Geoffroy, M | 1 |
| Afriat, M | 1 |
| Fauconier, M | 1 |
| Eschard, JP | 1 |
| Salmon, JH | 1 |
| Zimmermann-Górska, I | 1 |
| Hurni, Ch | 1 |
| Rauch, A | 1 |
| Trost, N | 1 |
| Perrig, M | 1 |
| Bürgi, U | 1 |
| Schoenenberger, AW | 1 |
| Corrao, S | 1 |
| Pistone, G | 1 |
| Scaglione, R | 1 |
| Colomba, D | 1 |
| Calvo, L | 1 |
| Licata, G | 1 |
| Alisky, JM | 1 |
| Banerjee, S | 1 |
| Brosnahan, G | 1 |
| Jiménez-Palop, M | 1 |
| Naredo, E | 1 |
| Humbrado, L | 1 |
| Medina, J | 1 |
| Uson, J | 1 |
| Francisco, F | 1 |
| García-Yebenes, MJ | 1 |
| Garrido, J | 1 |
| Macchioni, P | 8 |
| Catanoso, MG | 3 |
| Pipitone, N | 3 |
| Boiardi, L | 7 |
| Salvarani, C | 12 |
| López-Soto, A | 2 |
| Bosch, X | 1 |
| Agudo, M | 1 |
| Martinez-Dubois, C | 1 |
| Pompei, O | 1 |
| Andraghetti, G | 1 |
| Briatore, L | 1 |
| Salani, B | 1 |
| Parodi, M | 2 |
| Cutolo, M | 3 |
| Cordera, R | 1 |
| Lems, WF | 1 |
| Bijlsma, JW | 2 |
| Eizenga, WH | 1 |
| Hakvoort, L | 1 |
| Dubbeld, P | 1 |
| Geijer, RM | 1 |
| Goudswaard, AN | 1 |
| Rieck, KL | 1 |
| Thomsen, KM | 1 |
| Harmsen, WS | 1 |
| Karban, MJ | 1 |
| Braunert, L | 1 |
| Bruegel, M | 1 |
| Pfrepper, C | 1 |
| Thiery, J | 1 |
| Niederwieser, D | 1 |
| Ornetti, P | 1 |
| Guillibert-Karras, C | 1 |
| Garrot, JF | 1 |
| Gros, F | 1 |
| Gérard, N | 1 |
| Julien, L | 1 |
| Pascaud, F | 1 |
| Peere, T | 1 |
| Petit-Perrin, M | 1 |
| Piroth, C | 1 |
| Tavernier, C | 1 |
| Maillefert, JF | 1 |
| Wlazlo, N | 1 |
| Bravenboer, B | 1 |
| Pijpers, R | 1 |
| de Rijk, MC | 1 |
| Jover-Díaz, F | 1 |
| Gracia-Ruiz de Alda, M | 1 |
| Cuadrado-Pastor, JM | 1 |
| Martín-González, C | 1 |
| Montecucco, C | 2 |
| Caporali, R | 3 |
| Geijteman, E | 1 |
| Kramer, M | 1 |
| Nanayakkara, P | 1 |
| Mena-Madrazo, JA | 1 |
| Reyes, E | 1 |
| Flores-Suárez, LF | 1 |
| Cleuziou, C | 1 |
| Binard, A | 1 |
| Maradit-Kremers, H | 1 |
| Schmidt, WA | 1 |
| Schirmer, M | 1 |
| Bachta, A | 1 |
| Duftner, C | 1 |
| Slott Jensen, H | 1 |
| Poór, G | 1 |
| Kaposi, NP | 1 |
| Mandl, P | 1 |
| Balint, PV | 1 |
| Schmidt, Z | 1 |
| Iagnocco, A | 1 |
| Cantini, F | 2 |
| Nannini, C | 1 |
| Del Amo, M | 1 |
| Martínez-Taboada, VM | 2 |
| Nordborg, E | 1 |
| Direskeneli, H | 1 |
| Aydin, SZ | 1 |
| Ahmed, K | 1 |
| Hazelman, B | 1 |
| Pease, C | 1 |
| Wakefield, RJ | 1 |
| Luqmani, R | 1 |
| Abril, A | 1 |
| Marcus, R | 1 |
| Gonter, NJ | 1 |
| Maz, M | 1 |
| Crowson, CS | 1 |
| Arias-Urdaneta, L | 1 |
| Miloslavsky, E | 1 |
| Arvikar, S | 1 |
| Khosroshahi, A | 1 |
| Keroack, B | 1 |
| Stone, JR | 1 |
| Hirota, J | 1 |
| Kondo, S | 1 |
| Yamabe, T | 1 |
| Kondo, T | 1 |
| Seto, Y | 1 |
| Suzuki, S | 1 |
| Wiestner, A | 1 |
| Cho, HJ | 1 |
| Asch, AS | 1 |
| Michelis, MA | 1 |
| Zeller, JA | 1 |
| Peerschke, EI | 1 |
| Weksler, BB | 1 |
| Schechter, GP | 1 |
| MICKS, RH | 1 |
| MUNE, O | 1 |
| ROSSEL, I | 1 |
| MIRECKI, GB | 1 |
| Thierfelder, C | 1 |
| Hauser, T | 1 |
| de Klerk, E | 2 |
| van der Heijde, D | 2 |
| Landewé, R | 1 |
| van der Tempel, H | 1 |
| van der Linden, S | 1 |
| Catoggio, LJ | 1 |
| Montero Odasso, M | 1 |
| Soriano, ER | 1 |
| Imamura, PM | 1 |
| Camera, LA | 1 |
| Mayorga, LM | 1 |
| Ferraccioli, G | 2 |
| Klersy, C | 2 |
| Siegelmann-Danieli, N | 1 |
| Bardo, M | 1 |
| Law, A | 1 |
| Fisk, D | 1 |
| Bernath, A | 1 |
| Spiera, H | 6 |
| Knopman, D | 1 |
| Jankowiak, J | 1 |
| Sacks, O | 1 |
| Shulman, M | 1 |
| Coaccioli, S | 1 |
| Pinoca, F | 1 |
| Giuliani, M | 1 |
| Sabatini, C | 1 |
| Puxeddu, A | 1 |
| Ghose, RR | 1 |
| Sasaki, H | 1 |
| Washio, M | 1 |
| Ohara, N | 1 |
| Maruo, T | 1 |
| Awadh, B | 1 |
| Abdou, NI | 1 |
| Montecucco, CM | 1 |
| Cavagna, L | 1 |
| Capellino, S | 1 |
| Montagna, P | 1 |
| Fazzuoli, L | 1 |
| Villaggio, B | 1 |
| Seriolo, B | 2 |
| Sulli, A | 2 |
| Orzano, IM | 1 |
| Lally, EV | 1 |
| Keith, MP | 1 |
| Gilliland, WR | 1 |
| de Wolf, MM | 1 |
| van der Krans, A | 1 |
| Frijns, CJ | 1 |
| Unwin, B | 1 |
| Williams, CM | 1 |
| Gilliland, W | 1 |
| Vetter, C | 1 |
| Bonél, H | 1 |
| Burkhard, V | 1 |
| Bielecki, JW | 1 |
| Müller, BU | 1 |
| Manzini, C | 1 |
| Paolazzi, G | 1 |
| Trotta, A | 1 |
| Manganelli, P | 1 |
| Cimmino, M | 1 |
| Hunder, GG | 9 |
| Font, C | 2 |
| Sanmartí, R | 1 |
| Cañete, JD | 1 |
| Grau, JM | 2 |
| Krüger, K | 1 |
| Fu, HZ | 1 |
| Belloli, L | 1 |
| Massarotti, M | 1 |
| Marasini, B | 1 |
| Wilske, KR | 3 |
| Healey, LA | 6 |
| Gasparini, M | 1 |
| Federici, AB | 1 |
| Fox, RI | 1 |
| Espinoza, LR | 1 |
| Zimmerman, TS | 1 |
| Douglas, WA | 1 |
| Martin, BA | 1 |
| Morris, JH | 1 |
| Cantatore, FP | 1 |
| Carrozzo, M | 1 |
| D'Amore, M | 1 |
| Sabrà, C | 1 |
| Pipitone, V | 1 |
| Grau, RG | 1 |
| Kassan, SS | 1 |
| Franks, JJ | 1 |
| Kaplan, H | 1 |
| Walker, SH | 1 |
| Tan, EM | 1 |
| Gerber, NJ | 1 |
| Petrov, A | 1 |
| Koorey, DJ | 1 |
| Chou, CT | 1 |
| Schumacher, HR | 1 |
| Doury, P | 2 |
| Fabresse, FX | 1 |
| Pattin, S | 2 |
| Eulry, F | 2 |
| Celton, H | 1 |
| Larroque, P | 1 |
| Maurel, C | 1 |
| Masson, C | 1 |
| Tabaraud, F | 1 |
| Treadwell, BL | 1 |
| Davison, S | 3 |
| Heiligman, RM | 1 |
| Nightingale, S | 1 |
| Venables, GS | 1 |
| Bates, D | 1 |
| Bretza, J | 1 |
| Prete, P | 1 |
| Martin, D | 1 |
| Jones, JG | 1 |
| Hazleman, BL | 1 |
| Hahn, BH | 1 |
| Mazzaferri, EL | 2 |
| Littman, BH | 1 |
| Bjarnason, D | 1 |
| Bryant, G | 2 |
| Engelbrecht, J | 1 |
| Cohen, M | 1 |
| Mertz, L | 1 |
| Weaver, A | 1 |
| Airoldi, M | 1 |
| Fantasia, R | 1 |
| Cotti, D | 1 |
| Castiglioni, G | 1 |
| Pelucco, L | 1 |
| Kohli, M | 1 |
| Bennett, RM | 1 |
| Gabriel, SE | 2 |
| Gertz, MA | 1 |
| Bjornsson, J | 1 |
| Li, CY | 1 |
| Marsh, CB | 1 |
| Thurnheer, R | 1 |
| Salomon, F | 1 |
| Evans, JM | 2 |
| Vukov, LF | 1 |
| Roche, NE | 1 |
| Fulbright, JW | 2 |
| Wagner, AD | 1 |
| Goronzy, JJ | 2 |
| Weyand, CM | 2 |
| Rossi, F | 2 |
| Casadei-Maldini, M | 1 |
| Mancini, R | 3 |
| Beltrandi, E | 3 |
| Portioli, I | 3 |
| Plotkin, M | 1 |
| Ryu, JH | 1 |
| Cuddigan, JH | 1 |
| Armona, J | 1 |
| Rodríguez-Valverde, V | 2 |
| Figueroa, M | 1 |
| Fernández-Sueiro, JL | 1 |
| Martínez-Taboada, V | 1 |
| Mok, CC | 1 |
| Lau, CS | 1 |
| Kumana, CR | 1 |
| Casadei Maldini, M | 2 |
| Salaffi, F | 1 |
| De Vita, S | 1 |
| Casatta, L | 1 |
| Bartoli, E | 1 |
| Hubscher, O | 1 |
| Vilches, A | 1 |
| Solmesky, S | 1 |
| Riveros, D | 1 |
| van der Veen, MJ | 1 |
| Dinant, HJ | 1 |
| van Booma-Frankfort, C | 1 |
| van Albada-Kuipers, GA | 1 |
| Kachroo, A | 1 |
| Tello, C | 1 |
| Bais, R | 1 |
| Panush, RS | 1 |
| Feinberg, HL | 1 |
| Sherman, JD | 1 |
| Schrepferman, CG | 1 |
| Dietzen, CJ | 1 |
| Feinberg, GD | 1 |
| Coll-Vinent, B | 1 |
| Adachi, JD | 1 |
| Bensen, WG | 1 |
| Bell, MJ | 1 |
| Bianchi, FA | 1 |
| Cividino, AA | 1 |
| Craig, GL | 1 |
| Sturtridge, WC | 1 |
| Sebaldt, RJ | 1 |
| Steele, M | 1 |
| Gordon, M | 1 |
| Themeles, E | 1 |
| Tugwell, P | 1 |
| Roberts, R | 1 |
| Gent, M | 1 |
| Sunku, J | 1 |
| O'Fallon, WM | 1 |
| Bahlas, S | 1 |
| Ramos-Remus, C | 1 |
| Davis, P | 1 |
| Vogeser, M | 1 |
| Haas, A | 1 |
| Ruckdeschel, G | 1 |
| von Scheidt, W | 1 |
| Whittaker, PE | 1 |
| Fitzsimons, MG | 1 |
| Schippers, EF | 1 |
| de Meijer, PH | 1 |
| Meinders, AE | 1 |
| Roblot, P | 1 |
| Zaim, A | 1 |
| Azais, I | 1 |
| Ramassamy, A | 1 |
| Paccalin, M | 1 |
| Becq-Giraudon, B | 1 |
| Schnyder, P | 1 |
| Frey, D | 1 |
| Lacomis, D | 1 |
| Giuliani, MJ | 1 |
| Wasko, MC | 1 |
| Oddis, CV | 1 |
| Di Fazano, CS | 1 |
| Messica, O | 1 |
| Quennesson, S | 1 |
| Quennesson, ER | 1 |
| Inaoui, R | 1 |
| Vergne, P | 1 |
| Bonnet, C | 1 |
| Bertin, P | 1 |
| Trêves, R | 1 |
| Stey, C | 1 |
| Truninger, K | 1 |
| Marti, D | 1 |
| Vogt, P | 1 |
| Medici, TC | 1 |
| García-Porrúa, C | 2 |
| Vázquez-Caruncho, M | 1 |
| Dababneh, A | 1 |
| Hajeer, A | 1 |
| Ollier, WE | 1 |
| Pritt, WM | 1 |
| Solau-Gervais, E | 1 |
| Flipo, RM | 1 |
| van der Tempel, H | 1 |
| van der Linden, S | 1 |
| Calvo Romero, JM | 1 |
| Ramos Salado, JL | 1 |
| Pérez Miranda, M | 1 |
| Olivieri, I | 1 |
| Bruscas Izu, C | 1 |
| Medrano San Ildefonso, M | 1 |
| Simon, L | 1 |
| Fito, C | 1 |
| Pacheco, MJ | 1 |
| Delgado-Rodriguez, M | 1 |
| Brucato, A | 1 |
| Brambilla, G | 1 |
| Straub, RH | 1 |
| Foppiani, L | 1 |
| Prete, C | 1 |
| Pulsatelli, L | 1 |
| Giusti, M | 1 |
| Pizzorni, C | 1 |
| Manthorpe, R | 1 |
| Hansen, TM | 1 |
| Junker, P | 1 |
| Lorenzen, I | 1 |
| Utne, HE | 1 |
| Brostoff, H | 1 |
| Brostoff, J | 1 |
| Lovschall, S | 1 |
| Scharf, J | 1 |
| Nahir, M | 1 |
| Gross, MD | 1 |
| Borkin, MH | 1 |
| Rupp, S | 1 |
| Deding, A | 1 |
| Tougaard, L | 1 |
| Krogh Jensen, M | 1 |
| Rodbro, P | 1 |
| Ahmed, T | 1 |
| Braun, AI | 1 |
| Miller, LD | 1 |
| Stevens, MB | 1 |
| Kryl, P | 1 |
| Kaeser, HE | 1 |
| Rynes, RI | 1 |
| Mika, P | 1 |
| Bartholomew, LE | 1 |
| Sochocky, S | 1 |
| Florenzano, F | 1 |
| Gloger, S | 1 |
| Donoso, S | 1 |
| Vergara, F | 1 |
| Heyn, J | 1 |
| Hugod, C | 1 |
| Halberg, P | 1 |
| McCabe, ES | 1 |
| Ghose, MK | 1 |
| Shensa, S | 1 |
| Lerner, PI | 1 |
| Kosolcharoen, P | 1 |
| Magnin, GE | 1 |
| Canton, CG | 1 |
| Bernis, C | 1 |
| Paraiso, V | 1 |
| Barril, G | 1 |
| García, A | 1 |
| Osorio, C | 1 |
| Rincón, B | 1 |
| Traver, JA | 1 |
| Spacca, C | 1 |
| Lodi, L | 1 |
| Juchet, H | 1 |
| Arlet, P | 1 |
| Ollier, S | 1 |
| Montané de la Roque, P | 1 |
| Le Tallec, Y | 1 |
| Roig López de los Mozos, A | 1 |
| Calvo Catalá, J | 1 |
| Hortelano Martínez, E | 1 |
| Liñana Santafé, JJ | 1 |
| González-Cruz Cervellera, MI | 1 |
| Ballester Belda, JE | 1 |
| Faerk, KK | 1 |
| Gray, RE | 1 |
| Doherty, SM | 1 |
| Galloway, J | 1 |
| Coulton, L | 1 |
| de Broe, M | 1 |
| Kanis, JA | 1 |
| Lantin, JP | 1 |
| Duc, J | 1 |
| Ninet, JP | 1 |
| Bachet, P | 1 |
| Dumontet, CM | 1 |
| Du Colombier, PB | 1 |
| Stewart, MD | 1 |
| Pasquier, JH | 1 |
| Bromberg, MB | 1 |
| Donofrio, PD | 1 |
| Segal, BM | 1 |
| Auquier, L | 1 |
| Paolaggi, JB | 1 |
| Vachteheim, J | 1 |
| Vilímová, M | 1 |
| Docken, WP | 1 |
| Krall, PL | 1 |
| Mazanec, DJ | 1 |
| Wilke, WS | 1 |
| Reddy, KR | 1 |
| Lund, B | 1 |
| Egsmose, C | 1 |
| Jørgensen, S | 1 |
| Krogsgaard, MR | 1 |
| Wysenbeek, AJ | 1 |
| Leibovici, L | 1 |
| Mor, F | 1 |
| Atsmon, A | 1 |
| Elling, H | 1 |
| Elling, P | 1 |
| Robb-Nicholson, C | 1 |
| Chang, RW | 1 |
| Anderson, S | 1 |
| Roberts, WN | 1 |
| Longtine, J | 1 |
| Corson, J | 1 |
| Larson, M | 1 |
| George, D | 1 |
| Green, J | 1 |
| Pereira, M | 1 |
| Kaine, JL | 1 |
| Manz, HJ | 1 |
| Canter, HG | 1 |
| Melton, J | 1 |
| Huddleston, RE | 1 |
| Papadakis, MA | 1 |
| Schwartz, ND | 1 |
| Vasey, FB | 1 |
| Miller, RH | 1 |
| Chen, JJ | 1 |
| Ney, RL | 1 |
| Tumulty, P | 1 |
| Lauter, SA | 1 |
| Reece, D | 1 |
| Avioli, LV | 1 |
| Ayoub, WT | 1 |
| Franklin, CM | 1 |
| Torretti, D | 1 |
| Foad, BS | 1 |
| Sheon, RP | 1 |
| Kirsner, AB | 1 |
| Mumenthaler, M | 1 |
| Wadman, B | 1 |
| Werner, I | 1 |
| Harrison, MJ | 1 |
| Bevan, AT | 1 |
| Tallgren, LG | 1 |
| von Knorring, J | 1 |
| Beevers, DG | 1 |
| Harpur, JE | 1 |
| Turk, KA | 1 |
| Gatter, RA | 1 |
| McCarty, DJ | 1 |
| Hicklin, JA | 1 |
| Wills, MR | 1 |
| Cabanel, G | 1 |
| Voog, R | 1 |
| Phelip, X | 1 |
| Verdier, JM | 1 |
| Cosh, JA | 1 |
| Eisen, AA | 1 |
| Norris, JW | 1 |
| Thorpe, P | 1 |
| Fernandez-Herlihy, L | 1 |
| Anderson, LG | 1 |
| Bayles, TB | 1 |
| Vojtìsek, O | 1 |
| Kankovà, D | 1 |
| Fauchald, P | 1 |
| Rygvold, O | 1 |
| Oystese, B | 1 |
| Johnston, AC | 1 |
| Dickson, ER | 1 |
| Maldonado, JE | 1 |
| Sheps, SG | 1 |
| Cain, JA | 1 |
| Kanter, SF | 1 |
| Kogstad, O | 1 |
| Osnes, M | 1 |
| Lassen, J | 1 |
| MacKinnon, H | 1 |
| Menon, RS | 1 |
| Appenzeller, O | 1 |
| Scott, JT | 1 |
| Plotz, CM | 3 |
| Paulsen, S | 2 |
| Iversen, TO | 3 |
| Poniecki, A | 1 |
| Bernacka, K | 1 |
| Chwal, Z | 1 |
| Munthe, E | 1 |
| Christensen, MF | 1 |
| Somer, T | 1 |
| Sievers, K | 1 |
| Hart, FD | 1 |
| Simkin, PA | 1 |
| Waaler, G | 1 |
| Petera, V | 1 |
| Kogstad, OA | 1 |
| Polasky, N | 1 |
| Polasky, SH | 1 |
| Magenheim, H | 1 |
| Abrams, NR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica (ITTG PMR): An Open-label 52-week Randomized Controlled Trial[NCT06172361] | Phase 3 | 98 participants (Anticipated) | Interventional | 2024-01-15 | Not yet recruiting | ||
| Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE[NCT02908217] | Phase 3 | 113 participants (Actual) | Interventional | 2017-02-15 | Completed | ||
| Biomarkers in Giant Cells Arteritis[NCT02844023] | 100 participants (Actual) | Interventional | 2015-01-31 | Terminated (stopped due to recruitment failure) | |||
| Caractérisation Des Anomalies Immunologiques au Cours de la Pseudopolyarthrite rhizomélique et Effets du Traitement Par Tocilizumab[NCT02888496] | 40 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794] | Phase 3 | 94 participants (Anticipated) | Interventional | 2019-03-01 | Recruiting | ||
| Phase II Open 24 Weeks Study to Evaluate Effect and Safety of Tocilizumab as the First Line Therapy in Subjects With Polymyalgia Rheumatica (PMR)[NCT01713842] | Phase 2 | 21 participants (Actual) | Interventional | 2012-07-31 | Completed | ||
| Short Term Study on the Effect of a Fixed Dose of 12.5 mg of Prednisone as Starting Dose in Polymyalgia Rheumatica[NCT01169597] | Phase 4 | 60 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study[NCT02101333] | Phase 3 | 18 participants (Actual) | Interventional | 2014-06-10 | Completed | ||
| Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission: a Prospective, Pilot Study.[NCT03244709] | Phase 4 | 15 participants (Anticipated) | Interventional | 2015-01-01 | Recruiting | ||
| Observational Study to Determine the Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting[NCT02669355] | 123 participants (Actual) | Observational | 2015-10-31 | Completed | |||
| Is the Melanocortin System Involved in Inflammatory Resolution[NCT05681676] | 9 participants (Actual) | Observational | 2012-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
29 reviews available for prednisone and Polymyalgia Rheumatica
| Article | Year |
|---|---|
Corticosteroid Tapering Regimens in Rheumatic Disease: A Systematic Review.
Topics: Adrenal Cortex Hormones; Adult; Glucocorticoids; Humans; Methylprednisolone; Observational Studies a | 2020 |
Predicting the risk of relapse in polymyalgia rheumatica: novel insights.
Topics: Humans; Polymyalgia Rheumatica; Prednisone; Recurrence; Risk Factors | 2021 |
Diagnosis and management of polymyalgia rheumatica.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumati | 2016 |
Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Topics: Aged; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Middle Aged; Poly | 2018 |
Glucocorticoid-Induced Osteoporosis.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Bone; Gluco | 2018 |
Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literature.
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Panuveitis; Polymyalgia Rheumatica; Pred | 2016 |
Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Female; Glucocorticoids; Humans; Methotrexate; Middle Aged; | 2016 |
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Topics: Antibodies, Monoclonal, Humanized; Diagnostic Imaging; Drug Administration Schedule; Giant Cell Arte | 2016 |
[Diagnostics and treatment of polymyalgia rheumatica].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoimmune Diseases; Diagnosis, Differential; Dos | 2016 |
Polymyalgia rheumatica: clinical picture and principles of treatment.
Topics: Blood Sedimentation; C-Reactive Protein; Diagnosis, Differential; Glucocorticoids; Humans; Polymyalg | 2008 |
Treatment of polymyalgia rheumatica: a systematic review.
Topics: Aged; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; | 2009 |
Medical management of polymyalgia rheumatica.
Topics: Age Factors; Antirheumatic Agents; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Methot | 2010 |
Polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Diagnosis, Differential; Diagnostic Imaging; Giant Cell Arteritis; Glucocorticoids; Humans; Mi | 2006 |
[Therapy of polymyalgia rheumatica].
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anti-Inflammatory Agents; Benzodiazepines; Benzothiadiaz | 1984 |
[Giant cell arteritis. A study of 191 patients].
Topics: Aged; Aged, 80 and over; Biopsy; Blindness; Cause of Death; Female; Giant Cell Arteritis; Humans; Ma | 1995 |
Polymyalgia rheumatica. Relief can be dramatic.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Giant Cell Arteritis; Glucocorticoids; Humans | 1998 |
Bronchiolitis obliterans organizing pneumonia associated with polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cryptogenic Organizing Pneumonia; Diagnosis, Diff | 1999 |
Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Topics: C-Reactive Protein; CD8-Positive T-Lymphocytes; Flow Cytometry; Giant Cell Arteritis; Hematologic Te | 2001 |
Polymyalgia rheumatica and pericardial tamponade.
Topics: Aged; Anti-Inflammatory Agents; Cardiac Tamponade; Female; Humans; Pericardial Effusion; Pericardioc | 2002 |
Renal failure in temporal arteritis.
Topics: Aged; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Kid | 1992 |
[Temporal arteritis: diagnostic and therapeutic approach. What is new?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Giant Cell Arteritis; Polymyalgia Rheumatica; Predn | 1991 |
Giant cell arteritis and polymyalgia rheumatica.
Topics: Aged; Biopsy; Diagnosis, Differential; Drug Administration Schedule; Female; Fibromyalgia; Giant Cel | 1990 |
Low-dose prednisone therapy.
Topics: Acute Disease; Arthritis, Rheumatoid; Humans; Polymyalgia Rheumatica; Prednisone | 1989 |
Late-onset rheumatoid arthritis vs polymyalgia rheumatica: making the diagnosis.
Topics: Age Factors; Arthritis, Rheumatoid; Blood Sedimentation; Diagnosis, Differential; Humans; Middle Age | 1988 |
Adrenal steroid therapy in neurological disease. Part I.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Arteritis; Arthritis, Rheumatoid; Col | 1969 |
Polymyalgia rheumatica.
Topics: Adult; Aged; Arteritis; Biopsy; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Art | 1972 |
Polymyalgia rheumatica and giant cell arteritis.
Topics: Age Factors; Aged; Arteritis; Blood Sedimentation; Blood Vessels; Diagnosis, Differential; Female; H | 1974 |
[Polymyalgia rheumatica (comprehensive review)].
Topics: Age Factors; Aspirin; Blood Protein Electrophoresis; Blood Sedimentation; Diagnosis, Differential; G | 1973 |
Advances in the treatment of rheumatic disorders.
Topics: Alkylating Agents; Allopurinol; Analgesics; Anti-Inflammatory Agents; Antimalarials; Antimetabolites | 1968 |
21 trials available for prednisone and Polymyalgia Rheumatica
| Article | Year |
|---|---|
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc | 2022 |
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc | 2022 |
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc | 2022 |
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Monoc | 2022 |
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Topics: Antibodies, Monoclonal, Humanized; C-Reactive Protein; Drug Tapering; Glucocorticoids; Humans; Inter | 2023 |
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone | 2021 |
Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; C-Reactive Protein; Dose-Response Relationship, | 2018 |
Endothelial function and carotid intima-media thickness in giant-cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blood Flow Velocity; Brachial Artery; Carotid Art | 2014 |
Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pol | 2015 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Administration Schedule; Drug Th | 2016 |
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Deprescriptions; Female; Glucocorticoids | 2016 |
Patient-reported outcomes in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cohort Studies; Drug Monitoring; Female; Humans; | 2012 |
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Sched | 2004 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
[Clinical observation on effect of modified Yanghe Decoction combined with glycocorticoid for treatment of polymyalgia rheumatica].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; | 2007 |
Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Antirheumatic Agents; Blood Sedimentation; C-React | 2007 |
Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Dose-Respons | 1995 |
Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Blood Sedimentation; Bone Density; C-Reactive | 1996 |
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug A | 1996 |
Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Topics: Absorptiometry, Photon; Administration, Inhalation; Aged; Analgesics; Bone and Bones; Bone Density; | 1997 |
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocorticotropic Ho | 2002 |
[Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].
Topics: Administration, Oral; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Giant Cell | 1992 |
A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Calcium; Chro | 1991 |
Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Double-Blind Method; Female; Humans; Male; Middle | 1987 |
210 other studies available for prednisone and Polymyalgia Rheumatica
| Article | Year |
|---|---|
Giant cell arteritis with spontaneous remission.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; Remission, Spontaneo | 2022 |
Polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Hum | 2021 |
Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Arthritis, Rheum | 2022 |
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica.
Topics: Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone; | 2023 |
Development of a web tool to calculate the cumulative dose of glucocorticoids.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednisone | 2023 |
A pheochromocytoma on steroids.
Topics: Adrenal Gland Neoplasms; Aged; Female; Glucocorticoids; Humans; Pheochromocytoma; Polymyalgia Rheuma | 2020 |
Tunnel Vision in a Patient with Polymyalgia Rheumatica.
Topics: Adrenal Cortex Hormones; Aged; Biopsy; Fibrosis; Follow-Up Studies; Giant Cell Arteritis; Humans; Ma | 2020 |
Autoimmune Conditions: Polymyalgia Rheumatica and Dermatomyositis.
Topics: Dermatomyositis; Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia | 2020 |
Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumatica.
Topics: Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomogr | 2021 |
Onset of Kaposi sarcoma and Merkel cell carcinoma during low-dose steroid therapy for rheumatic polymyalgia.
Topics: Aged; Carcinoma, Merkel Cell; Female; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednisone; S | 2017 |
[Bilateral acute arteritic anterior ischemic optic neuropathy during chronic steroid therapy].
Topics: Aged, 80 and over; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Optic Neuropathy, Ischemic; | 2017 |
Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
Topics: Aged, 80 and over; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; Stroke | 2017 |
Therapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study.
Topics: Age Factors; Aged; Female; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Posit | 2018 |
76-Year-Old Man With New Bilateral Shoulder Pain.
Topics: Aged; Anti-Inflammatory Agents; Humans; Male; Polymyalgia Rheumatica; Prednisone; Shoulder Pain | 2018 |
Polymyalgia Rheumatica and Autoimmune Inflammatory Syndrome Induced by Adjuvants Following Administration of Influenza Vaccine.
Topics: Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Autoimmunity; Humans; Influenza Vaccines; Ma | 2018 |
Non-infective endocarditis: Expanding the phenotype of giant cell arteritis.
Topics: Aged, 80 and over; Aorta; Endocarditis, Non-Infective; Female; Giant Cell Arteritis; Glucocorticoids | 2019 |
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica Is Uncommon but May Be Enhanced by Amino Bisphosphonates.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonates; Ele | 2019 |
Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study.
Topics: Age Factors; Aged, 80 and over; Case-Control Studies; Female; Giant Cell Arteritis; Glucocorticoids; | 2019 |
Polymyalgia rheumatica occurrence under multikinase inhibitors (sorafenib and erlotinib) treatment.
Topics: Aged; Carcinoma, Hepatocellular; Erlotinib Hydrochloride; Glucocorticoids; Humans; Liver Neoplasms; | 2019 |
Polymyalgia rheumatica and giant cell arteritis: how best to approach these related diseases.
Topics: Anti-Inflammatory Agents; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Human | 2013 |
Positron emission tomography assessment for polymyalgia rheumatica.
Topics: Aged; C-Reactive Protein; Humans; Humerus; Male; Polymyalgia Rheumatica; Positron-Emission Tomograph | 2014 |
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis.
Topics: Aged; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Multimodal Imaging; Polymyalgia Rheuma | 2014 |
[Peripheral arthritis in polymyalgia rheumatica].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthralgia; Diagnosis, Differential; Female; Foot | 2014 |
Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients.
Topics: Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Drug | 2014 |
Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone.
Topics: Aged; Biomarkers; Cytokines; Female; Glucocorticoids; Humans; Inflammation; Interleukin-6; Male; Met | 2015 |
Polymyalgia rheumatica in a patient with splenic marginal zone lymphoma - a case report.
Topics: Drug Therapy, Combination; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Polymyalgia Rheumati | 2015 |
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumati | 2015 |
[Manifestations of polymialgia rheumatica in elderly].
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Comorbidity; Diagnosis, Differential; Humans; Male; Pai | 2015 |
Sterno-clavicular involvement in polymyalgia rheumatica.
Topics: Aged; Female; Glucocorticoids; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed | 2016 |
Polymyalgia Rheumatica Occurring in a Married Couple.
Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Male; Polymyalgia Rh | 2016 |
[No real alternatives to steroids yet].
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; Female; Humans; Male; Methotrexate | 2015 |
Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.
Topics: Agammaglobulinemia; Aged; Aged, 80 and over; B-Lymphocyte Subsets; Female; Giant Cell Arteritis; Glu | 2016 |
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) case presentation and comparison with other polyarthritides affecting older people.
Topics: Aged; Arthritis; Arthritis, Rheumatoid; Biomarkers; Diagnosis, Differential; Edema; Glucocorticoids; | 2017 |
Adverse effect of corticosteroid therapy: Central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Ma | 2018 |
[Pulmonary nodules in a patient on long-term steroid treatment].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Aged; Mycobacterium Infect | 2008 |
Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; | 2009 |
Do not overlook polymyalgia rheumatica as a cause for immobility in poorly communicating dementia patients.
Topics: Accidental Falls; Aged; Alzheimer Disease; Anti-Inflammatory Agents; Communication Disorders; Diagno | 2008 |
Polymyalgia rheumatica in a renal transplant patient.
Topics: Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunosuppression Therapy; Kidney Transpla | 2008 |
Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Bursitis; Drug Monitoring; Female; Follow-Up Studies; Glucocorticoids; Hip | 2010 |
Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Longitudinal Studies; Male; Polymyalgia Rh | 2009 |
Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica.
Topics: Adiponectin; Aged; Aged, 80 and over; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Dose-R | 2010 |
[Polymyalgia rheumatica: new possibilities for treatment, but not diagnosis].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Humans; Methotrexate; Polymyalgia Rheumatica; Predni | 2010 |
[Dutch College of General Practitioner's practice guideline on polymyalgia rheumatica and temporal arteritis].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Family Practice; Giant Cell Arteritis; Humans; Ne | 2010 |
Evaluation for clinical predictors of positive temporal artery biopsy in giant cell arteritis.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; | 2011 |
[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Cyclophospham | 2010 |
Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica.
Topics: Adrenal Cortex Hormones; Aged; Female; France; Health Knowledge, Attitudes, Practice; Humans; Male; | 2011 |
[Low back pain and MRI-abnormalities: atypical polymyalgia rheumatica].
Topics: Diagnosis, Differential; Humans; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; | 2011 |
[Shewanella algae bacteremia after contact with seawater in an immunocompromised patient].
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Bacteremia; Female; Gram-Negative Bacterial Infections; | 2011 |
The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity.
Topics: Administration, Oral; Aged; Analysis of Variance; Biomarkers; Blood Sedimentation; Body Weight; C-Re | 2011 |
Episodes of shortness of breath induced by prednisone.
Topics: Aged; Dyspnea; Female; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednisone | 2011 |
Giant cell arteritis in Mexican patients.
Topics: Aged; Aged, 80 and over; Amaurosis Fugax; Antirheumatic Agents; Blindness; Ethnicity; Female; Follow | 2012 |
Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Female; Glucocorticoids; Humans; Male; Pain Measurement | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; | 2012 |
Modified reduction aortoplasty with external reinforcement of the ascending aortic aneurysm caused by giant cell arteritis treated as polymyalgia rheumatica.
Topics: Aged; Aorta; Aortic Aneurysm; Aortic Valve; Aortic Valve Insufficiency; Female; Giant Cell Arteritis | 2013 |
Rituximab in the treatment of acquired factor VIII inhibitors.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Autoant | 2002 |
POLYMYALGIA RHEUMATICA--AN ESSAY IN DISCIPLESHIP.
Topics: Giant Cell Arteritis; Humans; Muscular Diseases; Polymyalgia Rheumatica; Prednisone; Rheumatic Disea | 1964 |
[POLYMYALGIA RHEUMATICA. REVIEW AND PERSONAL CASES].
Topics: Adrenocorticotropic Hormone; Arthritis; Blood Protein Electrophoresis; Diagnosis, Differential; Elec | 1964 |
[FURTHER EXPERIENCES WITH VERTEBRAN IN ORTHOPEDIC PRACTICE].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Atropine; Back Pain; Brachial Plexus | 1965 |
[An 80-year-old patient with known polymyalgia, worsening of general condition and weight loss].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Giant Ce | 2003 |
The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Colchici | 2003 |
Re: Guidelines for the diagnosis and management of PMR/GCA.
Topics: Aged; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; P | 2004 |
Summaries for patients. Prednisone plus methotrexate for polymyalgia rheumatica.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Sched | 2004 |
Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Female; Humans; Interferon alpha-2; Interferon-alph | 2004 |
Inflammatory diseases in older adults: polymyalgia rheumatica.
Topics: Aged; Diagnosis, Differential; Female; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheum | 2004 |
Patient page. Recovery from dementia: an interesting case.
Topics: Anti-Inflammatory Agents; Brain Diseases; Delirium; Dementia; Diagnosis, Differential; Drug Overdose | 2005 |
Steroid dementia: an overlooked diagnosis?
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Bipolar Disorder; Brain; Dementia; Diagnosis, Dif | 2005 |
[Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
Topics: Aged; Anti-Inflammatory Agents; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Female; Humans; Immunosup | 2005 |
A patient's diary.
Topics: Aged; Anti-Inflammatory Agents; Blood Sedimentation; Giant Cell Arteritis; Humans; Male; Patient Par | 2005 |
Acute onset of polymyalgia rheumatica in pregnancy.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Blood Sedimentation; C-Reactive Protein; Cesarean Se | 2005 |
Rising erythrocyte sedimentation rate in a patient with treated polymyalgia rheumatica: colon cancer as an accidental association versus paraneoplastic syndrome.
Topics: Adenocarcinoma; Aged, 80 and over; Anti-Inflammatory Agents; Blood Sedimentation; Colonic Neoplasms; | 2006 |
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; C-Reacti | 2006 |
Development of polymyalgia rheumatica in patients with scleroderma.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Middle A | 2006 |
Polymyalgia rheumatica and breast cancer.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Follow-Up Studies; Glucocortico | 2006 |
[Spontaneous bilateral rupture of the Achilles tendon in an elderly woman undergoing prednisone pulse therapy with a history of polymyalgia rheumatica].
Topics: Achilles Tendon; Aged, 80 and over; Female; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednis | 2006 |
[MRI-based diagnosis of giant cell arteritis].
Topics: Aortitis; Biopsy; Diagnosis, Differential; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosu | 2006 |
Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
[Polymyalgia rheumatica in the elderly. Muscle pain at night and in the morning].
Topics: Aged; Anti-Inflammatory Agents; Circadian Rhythm; Diagnosis, Differential; Female; Humans; Male; Mid | 2007 |
Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blindness; Female; Giant Cell Arteritis; Gluco | 2007 |
[Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Double-Blind Method; Giant Cell Arteritis; Humans; | 2007 |
Polymyalgia rheumatica and elderly onset rheumatoid arthritis.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Blood Sedimentation; Cohort Studies; Humans; | 2008 |
Polymyalgia rheumatica. A manifestation of systemic giant-cell arteritis.
Topics: Aged; Arteritis; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Pr | 1967 |
Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.
Topics: Aged; Blood Coagulation Factors; Blood Sedimentation; Choroiditis; Diagnosis, Differential; Female; | 1984 |
Polymyalgia rheumatica: an arthroscopic study of the shoulder joint.
Topics: Aged; Arthroscopy; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Polymyalgia Rh | 1983 |
[Polymyalgia rheumatica: a systemic vasculitis. Review of the literature and presentation of 2 clinical cases].
Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Female; Humans; Intermittent Claudication; M | 1984 |
Polymyalgia rheumatica and giant cell arteritis.
Topics: Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1984 |
Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
Topics: Aged; Antigens; Blood Sedimentation; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; G | 1984 |
Giant cell arteritis and its variants.
Topics: Aged; Aortic Arch Syndromes; Arterial Occlusive Diseases; Arteries; Cerebral Arterial Diseases; Diag | 1984 |
[Case description of rheumatic polymyalgia].
Topics: Diagnosis, Differential; Female; Humans; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1984 |
Cranial arteritis. A twenty-year review of cases.
Topics: Adult; Aged; Australia; Female; Giant Cell Arteritis; Headache; Humans; Male; Middle Aged; Polymyalg | 1984 |
Polymyalgia rheumatica.
Topics: Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Age | 1983 |
[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
Topics: Aged; Anemia, Hemolytic; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Iatrogeni | 1984 |
[Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis].
Topics: Aged; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone | 1983 |
Polymyalgia rheumatica.
Topics: Aged; Arteritis; Diagnosis, Differential; Humans; Middle Aged; Polymyalgia Rheumatica; Prednisone; S | 1981 |
Treatment of polymyalgia rheumatica.
Topics: Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone | 1982 |
Palindromic asymmetric polymyalgia rheumatica.
Topics: Aged; Female; Humans; Polymyalgia Rheumatica; Prednisone | 1982 |
Polymyalgia rheumatica with diffuse cerebral disease responding rapidly to steroid therapy.
Topics: Aged; Blood Sedimentation; Dementia; Diffuse Cerebral Sclerosis of Schilder; Electroencephalography; | 1982 |
Diagnostic errors in polymyalgia rheumatica and temporal arteritis.
Topics: Diagnostic Errors; Giant Cell Arteritis; Humans; Male; Middle Aged; Pancoast Syndrome; Polymyalgia R | 1981 |
Prognosis and management of polymyalgia rheumatica.
Topics: Giant Cell Arteritis; Humans; Nervous System Diseases; Polymyalgia Rheumatica; Prednisone; Prognosis | 1981 |
Glucocorticoid-induced osteoporosis.
Topics: Adolescent; Aged; Calcium; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Exe | 1995 |
[Giant-cell arteritis. Comments on the case histories of 30 patients].
Topics: Aged; Aged, 80 and over; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Midd | 1994 |
An association of polymyalgia rheumatica with myelodysplastic syndromes.
Topics: Aged; Blood Cell Count; Bone Marrow; Female; Humans; Methotrexate; Middle Aged; Myelodysplastic Synd | 1994 |
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.
Topics: Aged; Amyloidosis; Biopsy; Female; Giant Cell Arteritis; Humans; Intermittent Claudication; Male; Po | 1994 |
Shoulder and back pain with morning stiffness in an elderly woman.
Topics: Aged; Back Pain; Female; Humans; Pain; Polymyalgia Rheumatica; Prednisone; Shoulder | 1994 |
[Giant cell arteritis and aortic dissection in 2 siblings].
Topics: Aged; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; Female; Giant Cell A | 1993 |
Polymyalgia rheumatica and giant cell arteritis in emergency department patients.
Topics: Aged; Emergencies; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone | 1993 |
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Base Sequence; Giant Cell Arteritis; Humans; Interleukin-6; Longitudinal Studies; Middle Aged; | 1993 |
Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
Topics: Aged; Aged, 80 and over; CD4-CD8 Ratio; Female; Giant Cell Arteritis; Humans; Leukocyte Count; Lymph | 1993 |
Fatigue and edema in steroid therapy.
Topics: Aged; Bronchiolitis Obliterans; Edema; Fatigue; Female; Humans; Leg; Muscular Diseases; Pneumonia; P | 1993 |
Steroid treatment in giant cell arteritis.
Topics: Aged; Blindness; Female; Humans; Polymyalgia Rheumatica; Prednisone | 1993 |
Polymyalgia rheumatica as the rheumatological manifestation of myelodysplastic syndrome in a Chinese patient.
Topics: China; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Polymyalgia Rheumatica; Prednisone | 1996 |
CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy.
Topics: Age of Onset; Arthritis, Rheumatoid; CD4 Antigens; CD57 Antigens; CD8 Antigens; Female; Humans; Long | 1996 |
Polymyalgia rheumatica in patients with myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Fatal Outcome; Glucocorticoids; Humans; Male; Myelodysplastic Syndromes; Po | 1996 |
Giant cell arteritis: diagnosis and management.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Hum | 1996 |
The use of methotrexate in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; Drug Therapy, Combination; Female; Humans; Male; Metho | 1996 |
Case management study: an elderly patient with muscle pain.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Polymyalgia Rheumatica; Prednisone | 1997 |
Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.
Topics: Biopsy; Blindness; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methylprednisolone; | 1997 |
Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents | 1997 |
Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Female; Giant Ce | 1998 |
Steroid-induced invasive aspergillosis with thyroid gland abscess and positive blood cultures.
Topics: Abscess; Aged; Anti-Inflammatory Agents; Aspergillosis; Aspergillus fumigatus; Humans; Male; Polymya | 1998 |
A 24-year-old man with symptoms and signs of polymyalgia rheumatica.
Topics: Adult; Blood Sedimentation; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administ | 1998 |
[Clinical thinking and decision making in the practice. A patient with fever of unknown origin].
Topics: Aged; Anemia, Hypochromic; Biopsy; Blood Sedimentation; Female; Fever of Unknown Origin; Giant Cell | 1998 |
[RS3PE: a clinical diagnosis, a prognosis more simple than its name].
Topics: Aged; Aged, 80 and over; Ankle Joint; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Bl | 1998 |
[Polymyalgia rheumatica].
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Male; Polymyalgia Rheumatica; Predn | 1998 |
Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis.
Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Muscle Weakness | 1999 |
Corticosteroid requirements in polymyalgia rheumatica.
Topics: Acute Disease; Anti-Inflammatory Agents; Blood Sedimentation; Chronic Disease; Humans; Interleukin-6 | 1999 |
Two new cases of glucocorticoid-induced pancreatitis.
Topics: Acute Disease; Aged; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Pancreatitis; Polymyalg | 1999 |
The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
Topics: Age Factors; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Follow-Up Studies; Giant | 1999 |
You're the flight surgeon. Polymyalgia rheumatica.
Topics: Aerospace Medicine; Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Male; Middle Aged; Mi | 1999 |
[Rhizomelic pseudopolyarthritis: diagnosis, course, treatment].
Topics: Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; | 1999 |
Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Administration Sch | 1999 |
Getting the right diagnosis for aching muscles.
Topics: Aged; Female; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednisone | 1999 |
[Rheumatic polymyalgia].
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Polymyal | 2000 |
The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
Topics: Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheuma | 2000 |
[RS3PE syndrome: report of 11 cases].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Edema; Female; Humans; Mal | 2000 |
Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases.
Topics: Adult; Aged; Arthritis, Rheumatoid; Capillary Permeability; Dermatomyositis; Giant Cell Arteritis; H | 1979 |
Vitiligo and steroids.
Topics: Aged; Humans; Male; Polymyalgia Rheumatica; Prednisone; Remission, Spontaneous; Vitiligo | 1978 |
[Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica].
Topics: Aged; Azathioprine; Back Pain; Drug Evaluation; Drug Therapy, Combination; Female; Fractures, Sponta | 1977 |
Low-dose steroid treatment in polymyalgia rheumatica.
Topics: Humans; Polymyalgia Rheumatica; Prednisone; Recurrence | 1977 |
Unusual electromyographic findings in a patient with polymyalgia rheumatica.
Topics: Creatine Kinase; Electromyography; Female; Fructose-Bisphosphate Aldolase; Giant Cell Arteritis; Hum | 1979 |
Bone changes during prednisone treatment.
Topics: Aged; Bone and Bones; Drug Evaluation; Female; Giant Cell Arteritis; Humans; Hydroxyproline; Leukemi | 1977 |
Carpal tunnel syndrome with polymyalgia rheumatica.
Topics: Aged; Carpal Tunnel Syndrome; Female; Humans; Male; Polymyalgia Rheumatica; Prednisone | 1978 |
Skeletal manifestations of polymyalgia rheumatica.
Topics: Acromioclavicular Joint; Adult; Age Factors; Aged; Arthritis, Rheumatoid; Biopsy; Carpal Tunnel Synd | 1978 |
[The long-term prognosis of polymyalgia rheumatica (author's transl)].
Topics: Aged; Arteritis; Female; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Prognosis; R | 1979 |
Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.
Topics: Aged; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone | 1977 |
Polymyalgia arteritica.
Topics: Aged; Arteritis; Female; Humans; Polymyalgia Rheumatica; Prednisolone; Prednisone | 1977 |
Giant cell arteritis and blindness.
Topics: Aged; Blindness; Carotid Artery Diseases; Diagnosis, Differential; Giant Cell Arteritis; Humans; Mid | 1977 |
[Temporal arteritis (author's transl)].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1975 |
[Rheumatic polymyalgia--temporal arteritis. Temporary remission without glucocorticoid therapy].
Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; Remission, S | 1976 |
Polymyalgia rheumatica.
Topics: Aged; Blood Sedimentation; Female; Humans; Indomethacin; Male; Middle Aged; Polymyalgia Rheumatica; | 1976 |
Arteritis of the aged (giant cell arteritis) and fever of unexplained origin.
Topics: Aged; Anemia; Blood Sedimentation; Diagnosis, Differential; Female; Fever of Unknown Origin; Giant C | 1976 |
Liver dysfunction and polymyalgia rheumatica. A case report.
Topics: Aged; Alkaline Phosphatase; Female; Granuloma; Humans; Liver; Liver Diseases; Polymyalgia Rheumatica | 1976 |
Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Topics: Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Mal | 1992 |
[Immunosuppressor treatment in temporal arteritis of long-term evolution].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Female; Giant Cell Art | 1992 |
Simultaneous occurrence of polymyalgia rheumatica in a married couple.
Topics: Aged; Female; Humans; Male; Polymyalgia Rheumatica; Prednisone; Sweden; Time Factors | 1992 |
Giant cell arteritis and polymyalgia rheumatica.
Topics: Aged; Algorithms; Biopsy; Blood Sedimentation; Clinical Protocols; Decision Trees; Diagnosis, Differ | 1992 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1991. An 80-year-old woman with increasing dyspnea and extensive pulmonary opacities while receiving a decreasing prednisone dose for polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Lung; Polymyalgia Rheumatica; Pred | 1991 |
Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica.
Topics: Aged; Arm; Axillary Artery; Female; Giant Cell Arteritis; Humans; Ischemia; Middle Aged; Polymyalgia | 1990 |
Steroid-responsive electromyographic abnormalities in polymyalgia rheumatica.
Topics: Aged; Electromyography; Humans; Male; Polymyalgia Rheumatica; Prednisone | 1990 |
[Polymyalgia rheumatica and temporal arteritis. Observations on prognosis and treatment].
Topics: Biopsy; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisone; Prognosis | 1990 |
[Polymyalgia rheumatica, Takayasu's disease and the aortic arch syndrome].
Topics: Aged; Aortic Arch Syndromes; Aortography; Female; Humans; Polymyalgia Rheumatica; Prednisone; Takaya | 1989 |
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Ag | 1989 |
Liver abnormalities and persistent pain in limbs.
Topics: Hamartoma; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Polymyalgia Rheumatica; Predn | 1986 |
Diagnosis of polymyalgia rheumatica and giant cell arteritis: a note of caution.
Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Lymphoma; Male; Middle Aged; Mu | 1987 |
Decreased level of suppressor/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Leukocyte Count; Male; Middle Aged; Polymyalgia Rheumati | 1985 |
Diagnostic value of the history and examination in giant cell arteritis: a clinical pathological study of 81 temporal artery biopsies.
Topics: Aged; Aged, 80 and over; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Midd | 1988 |
Polymyalgia rheumatica and temporal arteritis: managing older patients.
Topics: Aged; Biopsy; Blood Sedimentation; Diagnosis, Differential; Giant Cell Arteritis; Humans; Polymyalgi | 1986 |
Trigeminal herpes zoster causing mandibular osteonecrosis and spontaneous tooth exfoliation.
Topics: Azathioprine; Cranial Nerve Diseases; Cyclophosphamide; Drug Therapy, Combination; Female; Herpes Zo | 1986 |
Polymyalgia rheumatica.
Topics: Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica | 1986 |
Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica.
Topics: Aged; Alkaline Phosphatase; Blood Sedimentation; Female; Giant Cell Arteritis; Hematocrit; Humans; P | 1986 |
Joint and muscle pains in an aging tennis player.
Topics: Aging; Humans; Male; Middle Aged; Pain; Polymyalgia Rheumatica; Prednisone; Tennis | 1985 |
Granulomatous angiitis presenting with polymyalgia rheumatica and abnormal pituitary function.
Topics: Female; Granuloma; Humans; Hypothalamic Diseases; Middle Aged; Obesity; Pituitary Diseases; Polymyal | 1985 |
Polymyalgia rheumatica and giant cell arteritis. The dilemma of therapy.
Topics: Aged; Blindness; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; P | 1985 |
Polymyalgia rheumatica.
Topics: Aged; Aging; Blood Sedimentation; Female; Humans; Ibuprofen; Middle Aged; Polymyalgia Rheumatica; Pr | 1985 |
Polymyalgia rheumatica. Duration of therapy and long-term outcome.
Topics: Actuarial Analysis; Aged; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mid | 1985 |
Systemic lupus erythematosus in the elderly.
Topics: Aged; Arthritis, Rheumatoid; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Ag | 1972 |
[Polymyalgia rheumatica and its treatment].
Topics: Alpha-Globulins; Arteritis; Biopsy; Blindness; Blood Sedimentation; Collagen Diseases; Giant Cell Ar | 1974 |
Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Poly | 1967 |
Early symptoms of temporal arteritis.
Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia | 1967 |
Renal vascular involvement in a case of polymyalgia rheumatica with temporal arteritis. A study of successive biopsies.
Topics: Aged; Biopsy; Blood Protein Electrophoresis; Blood Sedimentation; Female; gamma-Globulins; Giant Cel | 1969 |
Giant cell arteritis--the need for prolonged treatment.
Topics: Age Factors; Aged; Betamethasone; Biopsy; Blindness; Chronic Disease; Female; Giant Cell Arteritis; | 1973 |
Polymyalgia rheumatica. A rheumatic disease of the elderly.
Topics: Adrenocorticotropic Hormone; Aged; Female; Humans; Indomethacin; Male; Middle Aged; Phenylbutazone; | 1967 |
Plasma "cortisol" response to Synacthen in patients on long-term small-dose prednisone therapy.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Arthritis, Rheumatoid; Humans; Hydrocortisone; P | 1968 |
[Arterial involvements in Horton's disease].
Topics: Aortography; Arteritis; Arthritis; Biopsy; Femoral Artery; Giant Cell Arteritis; Headache; Humans; H | 1969 |
Anti-inflammatory drugs in rheumatic diseases.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Aspirin | 1974 |
Polymyalgia rheumatica: a not so benign syndrome.
Topics: Adrenocorticotropic Hormone; Aged; Arrhythmias, Cardiac; Blood Protein Electrophoresis; Diagnosis, D | 1969 |
Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.
Topics: Age Factors; Aged; Biopsy; Diagnosis, Differential; Eye Manifestations; Female; Giant Cell Arteritis | 1972 |
Giant-cell arteritis: ophthalmic and systemic considerations.
Topics: Age Factors; Aged; Arterial Occlusive Diseases; Arteritis; Biopsy; Blindness; Blood Sedimentation; D | 1973 |
Response to therapy confirms diagnosis.
Topics: Aged; Anemia; Blood Sedimentation; Diuretics; Edema; Female; Hemoglobinometry; Humans; Leukocytosis; | 1973 |
Polymyalgia rheumatica.
Topics: Humans; Polymyalgia Rheumatica; Prednisone | 1973 |
Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function.
Topics: Aged; Aortography; Arteritis; Biopsy; Female; Giant Cell Arteritis; Humans; Liver; Male; Middle Aged | 1973 |
Polymyalgia rheumatica: a review of recent literature.
Topics: Adult; Age Factors; Aged; Biopsy; Cortisone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged | 1973 |
[Polymyalgia rheumatica].
Topics: Biopsy; Diagnosis, Differential; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisone; S | 1973 |
[Arthritis and polymyalgia in Yersinia enterocolitica infections].
Topics: Adult; Aged; Arthritis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Erythema Nodosum; | 1974 |
Letter: Reaction to acetaminophen.
Topics: Acetaminophen; Bone Marrow Diseases; Female; Humans; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1974 |
Temporal arteritis.
Topics: Age Factors; Aged; Angiography; Biopsy; Blindness; Blood Proteins; Blood Sedimentation; Carotid Arte | 1974 |
Polymyalgia rheumatica.
Topics: Aged; Aspirin; Blood Chemical Analysis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Polymy | 1966 |
Rheumatic polymyalgia. Long-term treatment with steroids.
Topics: Aged; Blood Sedimentation; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Pol | 1971 |
[Polymyalgia rheumatica].
Topics: Calcium; Female; Humans; Middle Aged; Physical Therapy Modalities; Polymyalgia Rheumatica; Prednison | 1972 |
Polymyalgia rheumatica.
Topics: Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1970 |
Polymyalgia rheumatica.
Topics: Aged; Arteritis; Blood Sedimentation; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumat | 1969 |
[Polymyalgia rheumatica--clinical findings and treatment].
Topics: Humans; Polymyalgia Rheumatica; Prednisone | 1969 |
[Rheumatic polymyalgia. Long-term steroid therapy].
Topics: Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1971 |
[Polymyalgia rheumatica. A review and a report of personal cases].
Topics: Aged; Arthritis, Rheumatoid; Blood Protein Electrophoresis; Collagen Diseases; Diagnosis, Differenti | 1968 |
[Polymyalgia rheumatica].
Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; Middle Aged; Polymyalgia Rheum | 1968 |
Polymyalgia rheumatica.
Topics: Blood Sedimentation; Humans; Polymyalgia Rheumatica; Prednisolone; Prednisone | 1969 |
Giant cell arteritis with polymyalgia rheumatica, loss of vision, and abdominal symptoms occurring during a four year course.
Topics: Aged; Blindness; Blood Sedimentation; Diarrhea; Gastrointestinal Diseases; Giant Cell Arteritis; Hum | 1969 |
[Retroperitoneal fibrosis. A case with unusual symptomatology].
Topics: Aged; Anemia; Blood Sedimentation; Diagnosis, Differential; Female; Fever; Humans; Polymyalgia Rheum | 1969 |
[Chronic idiopathic dysproteinemia as an early symptom of temporal arteritis].
Topics: Aged; Blood Protein Disorders; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia | 1969 |
Polymyalgia rheumatica and its relation to arteritis temporalis.
Topics: Aged; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Midd | 1965 |
Giant-cell arteritis. Review and report of case.
Topics: Aged; Arteritis; Diagnosis, Differential; Female; Humans; Polymyalgia Rheumatica; Prednisone | 1965 |